← New search

Other meanings of Precision Medicine Initiative

U.S. biomedical research program

Precision Medicine Initiative

The Precision Medicine Initiative was a 2015 U.S. federal effort to advance individualized health care through large-scale research on genetics, environment, lifestyle, and health outcomes. Its principal public-facing research program became All of Us, an initiative intended to enroll at least one million people and create a diverse dataset for studying why prevention and treatment work differently among individuals.1

2015
Launched
Federal initiative announced
1 million+
Enrollment goal
Participants sought for All of Us
All of Us
Successor program
National longitudinal research cohort
1

Origins and scope

The initiative began in 2015 as a major U.S. investment in precision medicine, a model that combines individual biological variation with environmental, behavioral, and clinical information. President Barack Obama announced the effort in his State of the Union address, and the National Institutes of Health was charged with developing its research infrastructure. The program was not limited to genomic medicine: its proposed evidence base included electronic health records, biospecimens, mobile and wearable-device data, lifestyle information, and participant-reported outcomes.

In 2018, the cohort was formally named All of Us, shifting the emphasis toward broad participation and long-term partnership with volunteers.1 The name distinguishes the continuing cohort from the broader policy and research concept originally called the Precision Medicine Initiative.

2

All of Us as the core program

All of Us is a longitudinal research program designed to follow participants over time while linking multiple kinds of health information.2 Participants may contribute biological samples for genomic analysis, complete questionnaires, authorize access to relevant electronic health records, and connect data from digital health technologies. The resulting resource is intended for approved researchers studying disease risk, prevention, diagnosis, and treatment across populations.

A central objective is to improve representation in biomedical research. The program deliberately recruits people and communities often underrepresented in research, including racial and ethnic minorities, rural populations, older adults, and people with limited access to care.1 Diversity is treated as a scientific requirement because findings derived from narrow populations may not transfer reliably to everyone.

3

Data, access, and protections

The program’s scientific value depends on combining data sources while protecting participant privacy. All of Us separates identifying information from research data, uses controlled access and authentication, and applies governance procedures intended to reduce re-identification risks.3 Participants can review information about the program, change some sharing preferences, and withdraw from future participation, although data already distributed to researchers may not be recoverable.

Researchers do not receive an unrestricted public database. Registered investigators must complete training and use approved workspaces, with access levels varying according to the sensitivity of the data.4 The program also treats participant engagement as an ongoing relationship: its governance materials emphasize transparency, return of selected health-related findings, and community input rather than one-time collection alone.

4

Lesser-known aspects

The initiative’s distinctive feature is its breadth rather than a single diagnostic technology. Its design anticipates research questions that require linking genomics to social determinants, environmental exposure, medication history, physical activity, and changing health status. That makes the cohort useful for population health and prevention research as well as for treatment selection.

The program also illustrates a practical limit of the precision-medicine idea: a more detailed dataset does not automatically produce a better clinical decision. Researchers must address ancestry and genetic interpretation, missing or unevenly collected records, consent, data security, and the possibility that algorithms may reproduce existing inequities. The original initiative therefore joined technological goals to questions of ethics, public trust, and equitable participation. All of Us is the principal continuing expression of that agenda, while precision medicine remains the wider scientific and clinical framework.

Glossary

Precision medicine
An approach that uses differences in genes, environment, lifestyle, and other factors to improve prevention, diagnosis, or treatment for individuals or groups.
All of Us
The NIH research program that grew from the Precision Medicine Initiative and seeks to build a large, diverse, longitudinal health database.
Electronic health record
A digital record of a person’s clinical history, diagnoses, treatments, medications, and related health information.
Longitudinal study
Research that collects information from the same participants over an extended period.

The name Precision Medicine Initiative is used here for the U.S. federal initiative launched in 2015; its principal participant cohort was renamed the All of Us Research Program in 2018.